Symbols / OPGN $24.75 +0.00% CapForce Inc
OPGN Chart
About
CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.
Fundamentals
Scroll to Statements| Sector | Financial Services | Industry | Capital Markets | Market Cap | 251.20M |
| Enterprise Value | 152.55M | Income | 6.71M | Sales | 9.00M |
| Book/sh | 1.01 | Cash/sh | 0.04 | Dividend Yield | — |
| Payout | 0.00% | Employees | 1 | IPO | May 05, 2015 |
| P/E | 137.50 | Forward P/E | -85.34 | PEG | — |
| P/S | 27.91 | P/B | 24.53 | P/C | — |
| EV/EBITDA | 22.30 | EV/Sales | 16.95 | Quick Ratio | 5.70 |
| Current Ratio | 7.06 | Debt/Eq | 18.64 | LT Debt/Eq | — |
| EPS (ttm) | 0.18 | EPS next Y | -0.29 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2023-11-14 16:00 | ROA | 45.93% |
| ROE | 104.12% | ROIC | — | Gross Margin | 100.01% |
| Oper. Margin | 73.93% | Profit Margin | 76.04% | Shs Outstand | 10.15M |
| Shs Float | 3.16M | Short Float | 1.79% | Short Ratio | 1.23 |
| Short Interest | — | 52W High | 34.00 | 52W Low | 0.00 |
| Beta | -3052.63 | Avg Volume | 5.58K | Volume | 2.00K |
| Target Price | — | Recom | None | Prev Close | $24.75 |
| Price | $24.75 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-08-14 | down | HC Wainwright & Co. | Buy → Neutral | — |
| 2023-07-20 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
| 2023-06-26 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
| 2023-06-21 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
| 2023-05-16 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
- OpGen rebrands as CapForce, moves into digital investment banking - stocktitan.net Fri, 27 Feb 2026 08
- Dow Futures Push Higher After Breaking 50,000: Why OPGN, ACHR, LI, HIMS, CING Are Trending Today - Stocktwits Sat, 07 Feb 2026 08
- OPGEN INC SEC 10-Q Report - TradingView Wed, 01 Oct 2025 07
- OpGen, Inc. Rebrands as CapForce Inc. to Enter Digital Investment Banking Sector - Quiver Quantitative Fri, 27 Feb 2026 08
- OpGen pivots to FinTech CapForce; Q1 revenue $0, $5M equity stake, AEI funding - StockInvest.us Wed, 01 Oct 2025 07
- OPGN Stock Price, News & Analysis | Opgen - stocktitan.net Fri, 25 Apr 2025 02
- OpGen Announces Rapid Panel Test Results for COVID-19 Patients - thestreet.com ue, 09 Mar 2021 08
- OpGen faces Nasdaq delisting, to trade OTC - Investing.com Fri, 27 Dec 2024 08
- OpGen (NASDAQ: OPGN) up 611% - this is a wild, perhaps crazed, speculation - Dhaka Tribune hu, 12 Oct 2023 07
- OpGen Announced 1-for-10 Reverse Stock Split - Yahoo Finance hu, 16 May 2024 07
- Opgen Stock Price Forecast. Should You Buy OPGN? - StockInvest.us Wed, 02 Dec 2020 16
- Why Is Phio Pharma (PHIO) Stock Down 35% Today? - InvestorPlace hu, 12 Oct 2023 07
- Rockville biotech OpGen fights to retain Nasdaq listing as business teeters - The Business Journals Wed, 13 Dec 2023 08
- OpGen (NASDAQ: OPGN) stock - as we said, wild speculation now down 74% from peak - Dhaka Tribune Fri, 13 Oct 2023 07
- Was OpGen Inc's (NASDAQ:OPGN) Earnings Growth Better Than The Industry's? - simplywall.st hu, 17 May 2018 07
Insider Transactions
Financials
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
5.20
+52.01%
|
3.42
+31.11%
|
2.61
-39.45%
|
4.31
|
| Operating Revenue |
|
5.20
+52.01%
|
3.42
+31.11%
|
2.61
-39.45%
|
4.31
|
| Cost Of Revenue |
|
0.03
-99.05%
|
3.51
+2.48%
|
3.42
+20.21%
|
2.85
|
| Reconciled Cost Of Revenue |
|
0.03
-99.05%
|
3.51
+2.48%
|
3.42
+20.21%
|
2.85
|
| Gross Profit |
|
5.16
+5792.70%
|
-0.09
+88.90%
|
-0.82
-156.03%
|
1.46
|
| Operating Expense |
|
4.76
-69.46%
|
15.60
-27.12%
|
21.40
-12.86%
|
24.56
|
| Research And Development |
|
0.05
-98.97%
|
4.73
-42.09%
|
8.17
-25.09%
|
10.91
|
| Selling General And Administration |
|
4.71
-56.61%
|
10.86
-17.87%
|
13.23
-3.08%
|
13.65
|
| Selling And Marketing Expense |
|
0.17
-93.81%
|
2.78
-35.94%
|
4.34
+17.00%
|
3.71
|
| General And Administrative Expense |
|
4.54
-43.80%
|
8.08
-9.03%
|
8.88
-10.59%
|
9.94
|
| Other Gand A |
|
4.54
-43.80%
|
8.08
-9.03%
|
8.88
-10.59%
|
9.94
|
| Total Expenses |
|
4.80
-74.90%
|
19.11
-23.04%
|
24.83
-9.42%
|
27.41
|
| Operating Income |
|
0.40
+102.55%
|
-15.69
+29.39%
|
-22.22
+3.82%
|
-23.10
|
| Total Operating Income As Reported |
|
0.32
+101.06%
|
-30.75
+11.05%
|
-34.57
-48.53%
|
-23.27
|
| EBITDA |
|
12.35
+141.85%
|
-29.51
+8.87%
|
-32.38
-18.85%
|
-27.25
|
| Normalized EBITDA |
|
0.04
+100.26%
|
-14.23
+30.70%
|
-20.53
-0.91%
|
-20.34
|
| Reconciled Depreciation |
|
0.17
-86.75%
|
1.32
-19.73%
|
1.64
-39.47%
|
2.71
|
| EBIT |
|
12.18
+139.50%
|
-30.83
+9.40%
|
-34.03
-13.56%
|
-29.96
|
| Total Unusual Items |
|
12.31
+180.57%
|
-15.28
-28.92%
|
-11.85
-71.68%
|
-6.91
|
| Total Unusual Items Excluding Goodwill |
|
12.31
+180.57%
|
-15.28
-28.92%
|
-11.85
-71.68%
|
-6.91
|
| Special Income Charges |
|
12.31
+181.76%
|
-15.06
-21.96%
|
-12.35
-14030.94%
|
0.09
|
| Other Special Charges |
|
-10.31
|
—
|
—
|
-0.26
|
| Impairment Of Capital Assets |
|
-2.08
-199.93%
|
2.08
-83.15%
|
12.35
+7133.30%
|
0.17
|
| Restructuring And Mergern Acquisition |
|
—
|
—
|
—
|
0.00
|
| Net Income |
|
11.99
+136.71%
|
-32.67
+12.38%
|
-37.28
-7.12%
|
-34.81
|
| Pretax Income |
|
12.17
+137.25%
|
-32.67
+12.38%
|
-37.28
-7.25%
|
-34.76
|
| Net Non Operating Interest Income Expense |
|
0.36
+121.45%
|
-1.70
+47.14%
|
-3.21
+32.49%
|
-4.75
|
| Interest Expense Non Operating |
|
0.01
-99.59%
|
1.84
-43.53%
|
3.26
-32.15%
|
4.80
|
| Net Interest Income |
|
0.36
+121.45%
|
-1.70
+47.14%
|
-3.21
+32.49%
|
-4.75
|
| Interest Expense |
|
0.01
-99.59%
|
1.84
-43.53%
|
3.26
-32.15%
|
4.80
|
| Interest Income Non Operating |
|
0.37
+160.68%
|
0.14
+203.59%
|
0.05
+3.89%
|
0.05
|
| Interest Income |
|
0.37
+160.68%
|
0.14
+203.59%
|
0.05
+3.89%
|
0.05
|
| Other Income Expense |
|
11.41
+174.63%
|
-15.28
-28.92%
|
-11.85
-71.68%
|
-6.91
|
| Other Non Operating Income Expenses |
|
-0.91
|
—
|
—
|
—
|
| Gain On Sale Of Security |
|
0.00
+100.26%
|
-0.22
-145.29%
|
0.49
+107.05%
|
-6.99
|
| Gain On Sale Of Business |
|
-0.08
+99.42%
|
-12.98
|
0.00
|
—
|
| Tax Provision |
|
0.18
|
0.00
|
0.00
-100.00%
|
0.04
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.18
|
0.00
|
0.00
+100.00%
|
-1.86
|
| Net Income Including Noncontrolling Interests |
|
11.99
+136.71%
|
-32.67
+12.38%
|
-37.28
-7.12%
|
-34.81
|
| Net Income From Continuing Operation Net Minority Interest |
|
11.99
+136.71%
|
-32.67
+12.38%
|
-37.28
-7.12%
|
-34.81
|
| Net Income From Continuing And Discontinued Operation |
|
11.99
+136.71%
|
-32.67
+12.38%
|
-37.28
-7.12%
|
-34.81
|
| Net Income Continuous Operations |
|
11.99
+136.71%
|
-32.67
+12.38%
|
-37.28
-7.12%
|
-34.81
|
| Normalized Income |
|
-0.14
+99.21%
|
-17.38
+31.63%
|
-25.43
+14.57%
|
-29.76
|
| Net Income Common Stockholders |
|
11.36
+134.76%
|
-32.67
+12.38%
|
-37.28
+11.17%
|
-41.97
|
| Otherunder Preferred Stock Dividend |
|
—
|
—
|
0.00
-100.00%
|
7.17
|
| Diluted EPS |
|
2.30
+105.55%
|
-41.47
+72.84%
|
-152.70
+33.03%
|
-228.00
|
| Basic EPS |
|
2.44
+105.88%
|
-41.47
+72.84%
|
-152.70
+33.03%
|
-228.00
|
| Basic Average Shares |
|
4.66
+490.89%
|
0.79
+222.67%
|
0.24
+33.15%
|
0.18
|
| Diluted Average Shares |
|
5.22
+562.57%
|
0.79
+222.67%
|
0.24
+33.15%
|
0.18
|
| Diluted NI Availto Com Stockholders |
|
11.99
+136.71%
|
-32.67
+12.38%
|
-37.28
+11.17%
|
-41.97
|
| Average Dilution Earnings |
|
0.64
|
0.00
|
—
|
—
|
| Gain On Sale Of PPE |
|
—
|
—
|
—
|
0.00
|
| Preferred Stock Dividends |
|
0.64
|
—
|
—
|
—
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
9.86
+423.98%
|
1.88
-92.71%
|
25.81
-63.98%
|
71.67
|
| Current Assets |
|
2.65
+67.69%
|
1.58
-85.17%
|
10.66
-73.19%
|
39.74
|
| Cash Cash Equivalents And Short Term Investments |
|
1.31
+13.79%
|
1.15
-84.52%
|
7.44
-79.38%
|
36.08
|
| Cash And Cash Equivalents |
|
1.31
+13.79%
|
1.15
-84.52%
|
7.44
-79.38%
|
36.08
|
| Receivables |
|
0.03
-71.68%
|
0.10
-79.91%
|
0.51
-56.13%
|
1.17
|
| Accounts Receivable |
|
0.03
-71.68%
|
0.10
-79.91%
|
0.51
-56.13%
|
1.17
|
| Gross Accounts Receivable |
|
0.03
-71.68%
|
0.10
-79.91%
|
0.51
-56.13%
|
1.17
|
| Allowance For Doubtful Accounts Receivable |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Inventory |
|
—
|
0.00
-100.00%
|
1.35
+8.53%
|
1.24
|
| Raw Materials |
|
—
|
—
|
—
|
0.87
|
| Work In Process |
|
—
|
—
|
—
|
0.10
|
| Finished Goods |
|
—
|
—
|
—
|
3.74
|
| Prepaid Assets |
|
—
|
—
|
—
|
1.25
|
| Other Current Assets |
|
1.31
+303.20%
|
0.32
-76.05%
|
1.36
+8.45%
|
1.25
|
| Total Non Current Assets |
|
7.21
+2285.41%
|
0.30
-98.00%
|
15.16
-52.52%
|
31.92
|
| Net PPE |
|
1.90
+1380291.30%
|
0.00
-100.00%
|
4.92
-16.84%
|
5.92
|
| Gross PPE |
|
3.52
+140.33%
|
1.46
-83.69%
|
8.98
-5.00%
|
9.45
|
| Accumulated Depreciation |
|
-1.62
-10.31%
|
-1.46
+63.93%
|
-4.06
-14.79%
|
-3.54
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.45
+0.00%
|
0.45
-60.21%
|
1.14
-12.52%
|
1.30
|
| Other Properties |
|
1.44
+134.41%
|
0.61
-90.05%
|
6.18
-5.26%
|
6.52
|
| Leases |
|
1.63
+309.39%
|
0.40
-76.15%
|
1.67
+1.99%
|
1.63
|
| Goodwill And Other Intangible Assets |
|
—
|
0.00
-100.00%
|
7.44
-66.15%
|
21.98
|
| Goodwill |
|
—
|
—
|
0.00
-100.00%
|
7.45
|
| Other Intangible Assets |
|
—
|
—
|
7.44
-48.79%
|
14.53
|
| Investments And Advances |
|
5.00
|
0.00
|
—
|
—
|
| Non Current Deferred Assets |
|
0.01
|
0.00
|
—
|
—
|
| Other Non Current Assets |
|
0.30
+0.00%
|
0.30
-89.19%
|
2.80
-30.51%
|
4.02
|
| Total Liabilities Net Minority Interest |
|
2.48
-81.54%
|
13.44
-26.28%
|
18.24
-40.11%
|
30.45
|
| Current Liabilities |
|
0.63
-94.45%
|
11.42
+7.84%
|
10.59
-46.82%
|
19.92
|
| Payables And Accrued Expenses |
|
0.31
+24.59%
|
0.25
-87.33%
|
1.95
-40.51%
|
3.27
|
| Payables |
|
0.25
+120.60%
|
0.11
-73.59%
|
0.42
-67.80%
|
1.31
|
| Accounts Payable |
|
0.25
+120.60%
|
0.11
-73.59%
|
0.42
-67.80%
|
1.31
|
| Current Accrued Expenses |
|
0.06
-54.18%
|
0.14
-91.12%
|
1.53
-22.36%
|
1.97
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.06
-50.70%
|
0.13
-88.38%
|
1.10
-32.32%
|
1.62
|
| Current Debt And Capital Lease Obligation |
|
0.26
-97.60%
|
11.02
+48.85%
|
7.40
-50.71%
|
15.02
|
| Current Debt |
|
0.09
-99.17%
|
10.87
+54.81%
|
7.02
-51.62%
|
14.52
|
| Other Current Borrowings |
|
0.09
|
—
|
—
|
14.52
|
| Current Capital Lease Obligation |
|
0.17
+17.21%
|
0.15
-61.10%
|
0.38
-24.25%
|
0.50
|
| Current Deferred Liabilities |
|
0.00
-100.00%
|
0.03
-81.75%
|
0.14
|
0.00
|
| Current Deferred Revenue |
|
0.00
-100.00%
|
0.03
-81.75%
|
0.14
|
0.00
|
| Total Non Current Liabilities Net Minority Interest |
|
1.85
-8.59%
|
2.02
-73.56%
|
7.65
-27.41%
|
10.53
|
| Long Term Debt And Capital Lease Obligation |
|
1.85
-8.59%
|
2.02
-72.74%
|
7.42
-26.98%
|
10.16
|
| Long Term Debt |
|
—
|
—
|
4.85
-32.41%
|
7.18
|
| Long Term Capital Lease Obligation |
|
1.85
-8.59%
|
2.02
-21.23%
|
2.57
-13.91%
|
2.98
|
| Other Non Current Liabilities |
|
—
|
—
|
0.13
-11.87%
|
0.15
|
| Stockholders Equity |
|
7.38
+163.84%
|
-11.56
-252.62%
|
7.58
-81.62%
|
41.22
|
| Common Stock Equity |
|
7.38
+163.82%
|
-11.56
-252.65%
|
7.58
-81.62%
|
41.22
|
| Capital Stock |
|
0.10
+557.08%
|
0.02
+428.52%
|
0.00
-87.51%
|
0.02
|
| Common Stock |
|
0.10
+685.13%
|
0.01
+342.31%
|
0.00
-87.51%
|
0.02
|
| Preferred Stock |
|
0.00
-99.92%
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
10.07
+685.13%
|
1.28
+342.32%
|
0.29
+24.86%
|
0.23
|
| Ordinary Shares Number |
|
10.07
+685.13%
|
1.28
+342.32%
|
0.29
+24.86%
|
0.23
|
| Additional Paid In Capital |
|
300.78
+2.31%
|
293.99
+4.55%
|
281.19
+1.83%
|
276.15
|
| Retained Earnings |
|
-293.50
+3.93%
|
-305.49
-11.97%
|
-272.82
-15.83%
|
-235.54
|
| Gains Losses Not Affecting Retained Earnings |
|
0.00
+100.00%
|
-0.08
+90.56%
|
-0.80
-235.90%
|
0.59
|
| Other Equity Adjustments |
|
—
|
-0.08
+90.56%
|
-0.80
-235.90%
|
0.59
|
| Total Equity Gross Minority Interest |
|
7.38
+163.84%
|
-11.56
-252.62%
|
7.58
-81.62%
|
41.22
|
| Total Capitalization |
|
7.38
+163.84%
|
-11.56
-193.04%
|
12.43
-74.32%
|
48.39
|
| Working Capital |
|
2.02
+120.47%
|
-9.84
-15513.14%
|
0.06
-99.68%
|
19.83
|
| Invested Capital |
|
7.47
+1182.40%
|
-0.69
-103.55%
|
19.45
-69.08%
|
62.91
|
| Total Debt |
|
2.11
-83.81%
|
13.04
-12.00%
|
14.82
-41.13%
|
25.18
|
| Net Debt |
|
—
|
9.72
+119.23%
|
4.43
|
—
|
| Capital Lease Obligations |
|
2.02
-6.83%
|
2.17
-26.38%
|
2.95
-15.40%
|
3.48
|
| Net Tangible Assets |
|
7.38
+163.84%
|
-11.56
-8691.25%
|
0.13
-99.30%
|
19.23
|
| Tangible Book Value |
|
7.38
+163.82%
|
-11.56
-8693.10%
|
0.13
-99.30%
|
19.23
|
| Available For Sale Securities |
|
5.00
|
—
|
—
|
—
|
| Current Notes Payable |
|
0.00
-100.00%
|
10.87
+54.81%
|
7.02
-51.62%
|
14.52
|
| Derivative Product Liabilities |
|
—
|
0.00
-100.00%
|
0.10
-56.47%
|
0.23
|
| Investmentin Financial Assets |
|
5.00
|
0.00
|
—
|
—
|
| Other Inventories |
|
—
|
—
|
—
|
-3.47
|
| Preferred Stock Equity |
|
0.00
-99.92%
|
0.00
|
—
|
—
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.87
+65.99%
|
-14.32
+29.98%
|
-20.45
+4.79%
|
-21.48
|
| Cash Flow From Continuing Operating Activities |
|
-4.87
+65.99%
|
-14.32
+29.98%
|
-20.45
+4.79%
|
-21.48
|
| Net Income From Continuing Operations |
|
11.99
+136.71%
|
-32.67
+12.38%
|
-37.28
-7.12%
|
-34.81
|
| Depreciation Amortization Depletion |
|
0.17
-86.75%
|
1.32
-19.73%
|
1.64
-39.47%
|
2.71
|
| Depreciation And Amortization |
|
0.17
-86.75%
|
1.32
-19.73%
|
1.64
-39.47%
|
2.71
|
| Other Non Cash Items |
|
-10.87
-636.99%
|
2.02
-14.17%
|
2.36
-40.85%
|
3.99
|
| Pension And Employee Benefit Expense |
|
-0.57
|
0.00
|
—
|
—
|
| Stock Based Compensation |
|
0.60
+155.30%
|
0.24
-75.19%
|
0.95
+8.24%
|
0.88
|
| Provisionand Write Offof Assets |
|
-0.05
-106.87%
|
0.80
-49.57%
|
1.58
|
—
|
| Asset Impairment Charge |
|
-2.08
-199.93%
|
2.08
-83.15%
|
12.35
+7133.30%
|
0.17
|
| Operating Gains Losses |
|
-0.50
-103.83%
|
12.93
+13323.95%
|
-0.10
-101.28%
|
7.63
|
| Gain Loss On Investment Securities |
|
—
|
-0.06
+43.50%
|
-0.11
-101.44%
|
7.89
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.01
-35.70%
|
0.02
|
0.00
|
| Change In Working Capital |
|
-4.14
-299.75%
|
-1.03
+47.00%
|
-1.95
+4.85%
|
-2.05
|
| Change In Receivables |
|
0.07
+89.33%
|
0.04
-93.35%
|
0.59
+202.20%
|
-0.58
|
| Changes In Account Receivables |
|
0.07
+89.33%
|
0.04
-93.35%
|
0.59
+202.20%
|
-0.58
|
| Change In Inventory |
|
0.05
-92.67%
|
0.75
+202.73%
|
-0.73
+68.82%
|
-2.34
|
| Change In Payables And Accrued Expense |
|
0.42
+125.58%
|
-1.64
+22.12%
|
-2.10
-1707.40%
|
0.13
|
| Change In Accrued Expense |
|
0.28
+117.65%
|
-1.61
-25.24%
|
-1.29
-313.72%
|
0.60
|
| Change In Payable |
|
0.13
+654.88%
|
-0.02
+97.03%
|
-0.81
-72.59%
|
-0.47
|
| Change In Account Payable |
|
0.13
+654.88%
|
-0.02
+97.03%
|
-0.81
-72.59%
|
-0.47
|
| Change In Other Working Capital |
|
-0.03
-134.98%
|
0.07
-46.90%
|
0.14
+1523.02%
|
-0.01
|
| Change In Other Current Assets |
|
-4.66
-1697.09%
|
-0.26
-271.12%
|
0.15
-79.52%
|
0.74
|
| Investing Cash Flow |
|
0.00
+100.00%
|
-0.80
-35.49%
|
-0.59
+70.22%
|
-1.98
|
| Cash Flow From Continuing Investing Activities |
|
0.00
+100.00%
|
-0.80
-35.49%
|
-0.59
+70.22%
|
-1.98
|
| Net PPE Purchase And Sale |
|
0.00
+100.00%
|
-0.80
-35.49%
|
-0.59
+70.22%
|
-1.98
|
| Purchase Of PPE |
|
0.00
+100.00%
|
-0.80
-35.49%
|
-0.59
+70.22%
|
-1.98
|
| Capital Expenditure |
|
—
|
-0.80
-35.49%
|
-0.59
+70.22%
|
-1.98
|
| Net Business Purchase And Sale |
|
—
|
—
|
—
|
0.00
|
| Gain Loss On Sale Of Business |
|
0.08
-99.42%
|
12.98
|
0.00
|
—
|
| Financing Cash Flow |
|
5.03
-39.95%
|
8.37
+224.31%
|
-6.74
-114.19%
|
47.45
|
| Cash Flow From Continuing Financing Activities |
|
5.03
-39.95%
|
8.37
+224.31%
|
-6.74
-114.19%
|
47.45
|
| Net Issuance Payments Of Debt |
|
0.09
+102.30%
|
-3.92
+63.75%
|
-10.81
-1427.52%
|
-0.71
|
| Issuance Of Debt |
|
0.30
|
0.00
|
—
|
0.00
|
| Repayment Of Debt |
|
-0.21
+94.62%
|
-3.92
+63.75%
|
-10.81
-1427.52%
|
-0.71
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Long Term Debt Payments |
|
-0.00
+91.68%
|
-0.00
+92.20%
|
-0.04
+83.81%
|
-0.27
|
| Net Long Term Debt Issuance |
|
-0.00
+91.68%
|
-0.00
+92.20%
|
-0.04
+83.81%
|
-0.27
|
| Short Term Debt Issuance |
|
0.30
|
0.00
|
—
|
—
|
| Short Term Debt Payments |
|
-0.21
+94.62%
|
-3.91
+63.64%
|
-10.76
-2340.57%
|
-0.44
|
| Net Short Term Debt Issuance |
|
0.09
+102.31%
|
-3.91
+63.64%
|
-10.76
-2340.57%
|
-0.44
|
| Net Common Stock Issuance |
|
1.99
-83.49%
|
12.04
+195.69%
|
4.07
-83.68%
|
24.96
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
0.00
-100.00%
|
9.35
|
| Changes In Cash |
|
0.16
+102.35%
|
-6.75
+75.71%
|
-27.78
-215.79%
|
23.99
|
| Effect Of Exchange Rate Changes |
|
0.00
-100.00%
|
0.27
+128.80%
|
-0.92
+37.12%
|
-1.46
|
| Beginning Cash Position |
|
1.45
-81.68%
|
7.94
-78.34%
|
36.63
+159.67%
|
14.11
|
| End Cash Position |
|
1.61
+10.92%
|
1.45
-81.68%
|
7.94
-78.34%
|
36.63
|
| Free Cash Flow |
|
-4.87
+67.79%
|
-15.12
+28.14%
|
-21.04
+10.32%
|
-23.46
|
| Interest Paid Supplemental Data |
|
0.01
-99.47%
|
1.42
+31.97%
|
1.08
+20.54%
|
0.90
|
| Common Stock Issuance |
|
1.99
-83.49%
|
12.04
+195.69%
|
4.07
-83.68%
|
24.96
|
| Issuance Of Capital Stock |
|
4.94
-59.82%
|
12.29
+201.83%
|
4.07
-89.51%
|
38.81
|
| Net Preferred Stock Issuance |
|
2.95
+1080.09%
|
0.25
|
0.00
-100.00%
|
13.85
|
| Preferred Stock Issuance |
|
2.95
+1080.09%
|
0.25
|
0.00
-100.00%
|
13.85
|
| Sale Of Business |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-02-27 View
- 8-K2026-01-16 View
- 8-K2025-12-23 View
- 8-K2025-12-05 View
- 10-Q2025-11-19 View
- 10-Q2025-10-31 View
- 10-Q2025-10-01 View
- 10-K2025-08-21 View
- 42025-07-30 View
- 8-K2025-07-22 View
- 8-K2025-05-29 View
- 42025-04-30 View
- 8-K2024-12-27 View
- 42024-12-19 View
- 42024-12-19 View
- 42024-12-19 View
- 42024-12-19 View
- 42024-12-19 View
- 42024-12-19 View
- 42024-12-19 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|